Relapse After Allogeneic Hematopoietic Cell Therapy

Relapse of disease remains a major cause of mortality following allogeneic hematopoietic cell therapy (HCT). Over the past decade there has been a tremendous increase in our understanding of the biology underlying the graft-versus-tumor/leukemia (GVT) effect. However, there are several other factors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van den Brink, Marcel R.M., Porter, David L., Giralt, Sergio, Lu, Sydney X., Jenq, Robert R., Hanash, Alan, Bishop, Michael R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637945/
https://ncbi.nlm.nih.gov/pubmed/19857588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.10.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados